E
Rallybio Corporation RLYB
$0.626 $0.0325.39% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -41.65M -48.19M -57.78M -66.97M -73.88M
Total Depreciation and Amortization 116.00K 124.00K 131.00K 137.00K 142.00K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 8.40M 8.64M 8.62M 9.05M 9.30M
Change in Net Operating Assets -8.86M -4.61M -258.00K 6.72M 10.44M
Cash from Operations -41.99M -44.03M -49.28M -51.07M -53.99M
Capital Expenditure -- -- -- -12.00K -12.00K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 34.75M 34.31M 33.49M 51.99M 32.85M
Cash from Investing 34.75M 34.31M 33.49M 51.97M 32.84M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 28.00K 5.47M 5.47M 5.52M 5.52M
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -11.00K -268.00K -268.00K -269.00K -258.00K
Cash from Financing 17.00K 5.20M 5.20M 5.25M 5.26M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -7.23M -4.52M -10.59M 6.16M -15.89M